Otto O Ettala

9PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Radiation therapyMedical biotechnology diagnostics (incl. biosensors)Occupational epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Comparison of [18F]DCFPyL and [18F]FAPI-74 PET/CT imaging in metastatic prostate cancer.

|Mar 30, 2025
Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer.

Aino Kivikallio, Simona Malaspina, Irena Saarinen

|Mar 28, 2023
Short- and long-term risks of photoselective laser vaporization of the prostate: a population-based comparison with transurethral resection of the prostate.

Alisa Salmivalli, Otto Ettala, Pertti Nurminen

|Apr 29, 2022
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol.

Aino Siltari, Jarno Riikonen, Juha Koskimäki

|Apr 16, 2022
Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0).

Otto Ettala, Ivan Jambor, Ileana Montoya Perez

|Dec 28, 2019
Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer.

Otto Ettala, Simona Malaspina, Terhi Tuokkola

Pageof 2

Frequent Collaborators

3 joint publications

Pekka Taimen

3 joint publications

Peter J Boström

2 joint publications

Ivan Jambor

2 joint publications

Janne Verho